Figure 1.
Study population framework. KNHANES, Korean National Health and Nutrition Examination Survey; DR, diabetic retinopathy; DN, diabetic nephropathy.
*Subjects with fasting plasma glucose ≥126 mg/dL or a previous diagnosis of diabetes by a clinician, or who were taking insulin or oral antidiabetic medication. †Subjects diagnosed with diabetes by a clinician or taking insulin or oral antidiabetic agents.
Table 1.
Basic characteristics of the study participants.
Table 2.
Factors associated with receiving a dilated and comprehensive eye examination for diabetic retinopathy screening and microalbuminuria test for diabetic nephropathy screening during the previous year.
Table 3.
Factors associated with receiving screening for both diabetic retinopathy and diabetic nephropathy according to diabetes duration.